SCHEMBL12539799

SCHEMBL12539799

O=C1CCC(c2ccccc2)C(c2ccccc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
MAOB P27338 8/20 0.40
MAOA P21397 7/20 0.40
KDM1A O60341 5/20 0.40
CYP2C19 P33261 5/20 0.40
CYP2B6 P20813 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
LMNA P02545 2/20 0.40
TAAR1 Q96RJ0 2/20 0.40
CYP3A4 P08684 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CYP2A6 P11509 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2C P28335 1/20 0.40
ADRA1A P35348 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1945380 1.00 GAA (0.45) GAAMAPTMAOBMAOAKDM1A
SCHEMBL17968615 1.00 GAA (0.45) GAAMAPTMAOBMAOAKDM1A
SCHEMBL15831780 0.84 MAOB (0.54) GAAMAPTMAOBMAOAKDM1A
SCHEMBL3666782 0.84 MAOB (0.54) GAAMAPTMAOBMAOAKDM1A
SCHEMBL16581579 0.84 MAPT (0.42) GAAMAPTMAOBMAOAKDM1A
SCHEMBL8634111 0.82 GAA (0.41) GAAMAPTMAOBMAOAKDM1A
SCHEMBL7563424 0.80 MAPT (0.68) GAAMAPTMAOBMAOAKDM1A
SCHEMBL2507229 0.80 MEN1 (0.48) GAAMAPTLMNAKMT2AMEN1
SCHEMBL1695729 0.80 MEN1 (0.48) GAAMAPTLMNAKMT2AMEN1
SCHEMBL2507227 0.80 MEN1 (0.48) GAAMAPTLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160229778-A1 DIRECT B-ARYLATION OF CARBONYL COMPOUNDS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2016-08-11 US disclosed
US-20110136787-A1 DIPHENYL AZEPANE, DIAZEPANE AND OXAZEPANE DERIVATIVES AND USES THEREOF SCHOENFELD RYAN CRAIG 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136787-A1 DIPHENYL AZEPANE, DIAZEPANE AND OXAZEPANE DERIVATIVES AND USES THEREOF PTGDR2, PTGDR, TBXA2R GAA 3391/4885MAPT 3484/4885MAOB 484/4885
US-20160229778-A1 DIRECT B-ARYLATION OF CARBONYL COMPOUNDS DBH, DDT, CBR3 GAA 2417/4885MAPT 4423/4885MAOB 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.